However, a meta-analysis of 33 studies did not confirm a positive relationship between incretin-based therapies and pancreatic cancer and a causal relationship between incretin-based therapies and pancreatic cancer or pancreatitis is no known [59,60]. The gene discussed is GCG; the disease is pancreatitis.